dc.creatorMaya Arango, Juan
dc.creatorBollo Dragnic, Soledad
dc.creatorNúñez Vergara, Luis
dc.creatorSquella Serrano, Juan
dc.creatorRepetto Scaramelli, Yolanda
dc.creatorMorello Casté, Antonio
dc.creatorPerie, J.
dc.creatorChauviere, G.
dc.date.accessioned2008-06-11T17:02:48Z
dc.date.available2008-06-11T17:02:48Z
dc.date.created2008-06-11T17:02:48Z
dc.date.issued2003-03-15
dc.identifierBIOCHEMICAL PHARMACOLOGY 65(6):999-1006
dc.identifier0006-2952
dc.identifierhttp://repositorio.uchile.cl/handle/2250/120452
dc.description.abstractWith the aim of determining the actual target(s) of nitro-group bearing compounds considered as possible leads for the development of drugs against Chagas' disease, we studied in parallel nitrofurans and nitroimidazoles. We investigated nine representative compounds for the following properties: efficacy on different Trypanosoma cruzi strains, redox cyclers, inhibition of respiration, production of corresponding nitroso derivatives and intracellular thiol scavengers. Our results indicate that nifurtimox and related compounds act as redox cyclers, whereas the most active in the series, the 5-nitroimidazole megazol essentially acts as thiol scavenger particularly for trypanothione, the cofactor for trypanothione reductase, an essential enzyme in the detoxification process.
dc.languageen
dc.publisherPERGAMON-ELSEVIER SCIENCE
dc.subjectnitroimidazoles
dc.titleTrypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución